James H. Tonsgard

3.8k total citations
43 papers, 1.4k citations indexed

About

James H. Tonsgard is a scholar working on Neurology, Clinical Biochemistry and Molecular Biology. According to data from OpenAlex, James H. Tonsgard has authored 43 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Neurology, 13 papers in Clinical Biochemistry and 8 papers in Molecular Biology. Recurrent topics in James H. Tonsgard's work include Neurofibromatosis and Schwannoma Cases (20 papers), Metabolism and Genetic Disorders (13 papers) and Meningioma and schwannoma management (5 papers). James H. Tonsgard is often cited by papers focused on Neurofibromatosis and Schwannoma Cases (20 papers), Metabolism and Genetic Disorders (13 papers) and Meningioma and schwannoma management (5 papers). James H. Tonsgard collaborates with scholars based in United States, Japan and Canada. James H. Tonsgard's co-authors include M. Priscilla Short, Godfrey S. Getz, Abraham H. Dachman, Sandy Kwak, Bruce H. Wainer, Henry J. Lee, David N. Hammond, Bruce H. Wainer, Alfred Heller and Valerie Lindgren and has published in prestigious journals such as Science, Journal of Clinical Investigation and Journal of Clinical Oncology.

In The Last Decade

James H. Tonsgard

42 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
James H. Tonsgard United States 20 646 455 308 238 235 43 1.4k
Masamichi Ikawa Japan 24 472 0.7× 617 1.4× 157 0.5× 128 0.5× 130 0.6× 90 1.6k
Chantal Tallaksen Norway 29 1.0k 1.6× 604 1.3× 107 0.3× 140 0.6× 207 0.9× 77 2.3k
Judith C. Fleming United States 17 449 0.7× 390 0.9× 33 0.1× 189 0.8× 126 0.5× 19 1.6k
Mary Kay Koenig United States 21 190 0.3× 1.1k 2.5× 103 0.3× 93 0.4× 677 2.9× 61 2.0k
Steven R. Ennis United States 22 339 0.5× 468 1.0× 196 0.6× 19 0.1× 61 0.3× 30 1.5k
Anne G. Gilg United States 14 173 0.3× 511 1.1× 90 0.3× 47 0.2× 67 0.3× 16 1.1k
Ewa Pronicka Poland 26 82 0.1× 1.2k 2.5× 114 0.4× 172 0.7× 553 2.4× 114 2.0k
Birgit Assmann Germany 23 342 0.5× 870 1.9× 58 0.2× 163 0.7× 789 3.4× 51 1.7k
Yasuaki Nishimura Japan 19 314 0.5× 606 1.3× 151 0.5× 97 0.4× 11 0.0× 56 1.4k
Joan Keutzer United States 29 406 0.6× 498 1.1× 673 2.2× 662 2.8× 245 1.0× 50 2.7k

Countries citing papers authored by James H. Tonsgard

Since Specialization
Citations

This map shows the geographic impact of James H. Tonsgard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James H. Tonsgard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James H. Tonsgard more than expected).

Fields of papers citing papers by James H. Tonsgard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James H. Tonsgard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James H. Tonsgard. The network helps show where James H. Tonsgard may publish in the future.

Co-authorship network of co-authors of James H. Tonsgard

This figure shows the co-authorship network connecting the top 25 collaborators of James H. Tonsgard. A scholar is included among the top collaborators of James H. Tonsgard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James H. Tonsgard. James H. Tonsgard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Plotkin, Scott R., Jeffrey C. Allen, Girish Dhall, et al.. (2023). Multicenter, prospective, phase II study of maintenance bevacizumab for children and adults with NF2-related schwannomatosis and progressive vestibular schwannoma. Neuro-Oncology. 25(8). 1498–1506. 12 indexed citations
3.
Wolters, Pamela L., Ana‐Maria Vranceanu, Staci Martin, et al.. (2021). Current Recommendations for Patient-Reported Outcome Measures Assessing Domains of Quality of Life in Neurofibromatosis Clinical Trials. Neurology. 97(7_Supplement_1). S50–S63. 19 indexed citations
4.
Plotkin, Scott R., Dan G. Duda, Alona Muzikansky, et al.. (2019). Multicenter, Prospective, Phase II and Biomarker Study of High-Dose Bevacizumab as Induction Therapy in Patients With Neurofibromatosis Type 2 and Progressive Vestibular Schwannoma. Journal of Clinical Oncology. 37(35). 3446–3454. 74 indexed citations
5.
Klein-Tasman, Bonnie, et al.. (2013). Cognitive and Psychosocial Phenotype of Young Children with Neurofibromatosis-1. Journal of the International Neuropsychological Society. 20(1). 88–98. 35 indexed citations
6.
7.
Tonsgard, James H.. (2006). Clinical Manifestations and Management of Neurofibromatosis Type 1. Seminars in Pediatric Neurology. 13(1). 2–7. 158 indexed citations
8.
Frank, Jeffrey I., et al.. (2003). Decompressive Hemicraniectomy in a 6-Year-Old Male after Unilateral Hemispheric Stroke. Pediatric Neurosurgery. 38(4). 181–185. 24 indexed citations
9.
Miller, M., et al.. (2000). Late‐onset neurofibromatosis in a liver transplant recipient. International Journal of Dermatology. 39(5). 376–379. 2 indexed citations
10.
Stevenson, David A., Patricia Birch, Jan M. Friedman, et al.. (1999). Descriptive analysis of tibial pseudarthrosis in patients with neurofibromatosis 1. American Journal of Medical Genetics. 84(5). 413–419. 96 indexed citations
11.
Alexander, Jessy J., Ann K. Snyder, & James H. Tonsgard. (1998). Omega-Oxidation of Monocarboxylic Acids in Rat Brain. Neurochemical Research. 23(2). 227–233. 20 indexed citations
12.
Alexander, J. J., Probal Banerjee, Glyn Dawson, & James H. Tonsgard. (1995). Hyperammonemia increases serotonin 1A receptor expression in both rat hippocampus and a transfected hippocampal cell line, HN2‐5. Journal of Neuroscience Research. 41(1). 105–110. 7 indexed citations
13.
Aoyama, Toshifumi, Yasushi Uchida, Richard I. Kelley, et al.. (1993). A Novel Disease with Deficiency of Mitochondrial Very-Long-Chain Acyl-CoA Dehydrogenase. Biochemical and Biophysical Research Communications. 191(3). 1369–1372. 122 indexed citations
14.
Tonsgard, James H., et al.. (1993). Cerebral malformations in Carpenter syndrome. Pediatric Neurology. 9(3). 230–234. 14 indexed citations
15.
Maselli, Ricardo A., Margaret Burnett, & James H. Tonsgard. (1992). In vitro microelectrode study of neuromuscular transmission in a case of botulism. Muscle & Nerve. 15(3). 273–276. 19 indexed citations
16.
Tonsgard, James H., Janet K. Stephens, William J. Rhead, et al.. (1991). Defect in fatty acid oxidation: Laboratory and pathologic findings in a patient. Pediatric Neurology. 7(2). 125–130. 5 indexed citations
17.
Tonsgard, James H., et al.. (1991). Induction of omega-oxidation of monocarboxylic acids in rats by acetylsalicylic acid.. Journal of Clinical Investigation. 88(6). 1865–1872. 22 indexed citations
18.
Tonsgard, James H., S. Mendelson, & Stephen C. Meredith. (1988). Binding of straight-chain saturated dicarboxylic acids to albumin.. Journal of Clinical Investigation. 82(5). 1567–1573. 13 indexed citations
19.
Tonsgard, James H., et al.. (1987). Kluver-Bucy syndrome in children. Pediatric Neurology. 3(3). 162–165. 21 indexed citations
20.
Tonsgard, James H., Peter R. Huttenlocher, & Ronald A. Thisted. (1982). Lactic acidemia in Reye's syndrome.. PubMed. 69(1). 64–9. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Masamichi Ikawa Breakdown of academic impact, for papers by Chantal Tallaksen Breakdown of academic impact, for papers by Judith C. Fleming Breakdown of academic impact, for papers by Mary Kay Koenig Breakdown of academic impact, for papers by Steven R. Ennis Breakdown of academic impact, for papers by Anne G. Gilg Breakdown of academic impact, for papers by Ewa Pronicka Breakdown of academic impact, for papers by Birgit Assmann Breakdown of academic impact, for papers by Yasuaki Nishimura Breakdown of academic impact, for papers by Joan Keutzer
Rankless by CCL
2026